(Q41035988)

25 September 2017

1 reference

title

Genetic basis and clonal evolution of human prostate cancer (English)

1 reference

25 September 2017

Genetic Basis and Clonal Evolution of Human Prostate Cancer (English)

0 references

1 reference

Olli-Pekka Kallioniemi

1 reference

ORCID Public Data File 2021

author name string

Olli-P. Kallioniemi

series ordinal

1

1 reference

25 September 2017

Tapio Visakorpi

series ordinal

2

1 reference

25 September 2017

1 January 1996

1 reference

Advances in Cancer Research

25 September 2017

1996

0 references

published in

1 reference

25 September 2017

68

1 reference

25 September 2017

225-255

1 reference

Clues to the pathogenesis of familial colorectal cancer

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Oncogenic activity of the c-Myc protein requires dimerization with Max.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Immunohistochemical determination of p53 protein nuclear accumulation in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Cytogenetic survey of 32 cancers of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Chromosome study of five cancers of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Cytogenetic study of four cancers of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Proving early detection and treatment of prostate cancer does more good than harm: the need to support randomized trials actively

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Telomeric and nontelomeric (TTAGGG)n sequences in gene amplification and chromosome stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Somatic allelic loss at the DCC, APC, nm23-H1 and p53 tumor suppressor gene loci in human prostatic carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Cytogenetic evaluation of 20 cultured primary prostatic tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Evaluation of 20 archival prostate tumor specimens by fluorescence in situ hybridization (FISH).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: characterization of the human E-cadherin gene promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

p53 oncogene mutations in three human prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Epidemiologic evidence regarding predisposing factors to prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Allelic loss of chromosomes 16q and 10q in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Mendelian inheritance of familial prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Telomerase activity in human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Frequency and characterization of p53 mutations in primary and metastatic human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Mutation of the MXI1 gene in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Gene amplifications in advanced-stage human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Analysis of gene amplification in human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

The dilemmas of prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Histologic grading of prostate cancer: a perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Frequency and characterization of p53 mutations in clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Clinical implications of the p53 tumor-suppressor gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Frequency and distribution of numerical chromosomal aberrations in prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Specific association of human telomerase activity with immortal cells and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

The cell adhesion regulator (CAR) gene, TaqI and insertion/deletion polymorphisms, and regional assignment to the peritelomeric region of 16q by linkage analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Allelotyping of human prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Oncogene amplifications in early-stage human prostate carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Multiple structural chromosome rearrangements, including del(7q) and del(10q), in an adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Cytogenetic analysis of 57 primary prostatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Extensive genetic alterations in prostate cancer revealed by dual PCR and FISH analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

c-erbB-2 oncoprotein expression in primary human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Accumulation of the p53 protein occurs more frequently in metastatic than in localized prostatic adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

The impact of family history on early detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Androgen receptor gene mutations in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

The clonal evolution of tumor cell populations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

E-cadherin: a marker for differentiation and invasiveness in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Use of fluorescent in situ hybridization for deoxyribonucleic acid ploidy analysis of prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

The role of increasing detection in the rising incidence of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Cloning and characterization of a human c-myc promoter-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Chromosomal abnormalities and related events in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Microsatellite mutation (CAG24-->18) in the androgen receptor gene in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Chromosome aberrations and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

DNA aneuploidy in prostatic adenocarcinoma: a frequent event as shown by fluorescence in situ DNA hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Family history and the risk of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Androgen receptor gene mutations in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

p53 expression and clinical outcome in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Normal diploid human and rodent cells lack a detectable frequency of gene amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

p53 oncogene mutations in human prostate cancer specimens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

International comparison on ras gene mutations in latent prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Geographic pathology of latent prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Cancer of the prostate: epidemiology and aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Alterations of the P53 gene are associated with the progression of a human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

Loss of heterozygosity and overexpression of p53 gene in human primary prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-230X%2808%2960355-3

7 January 2021

10.1016/S0065-230X(08)60355-3

Identifiers

DOI

0 references

1 reference